OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers …
Over the last 12 months, insiders at OPKO Health, Inc. have bought $11.95M and sold $0 worth of OPKO Health, Inc. stock.
On average, over the past 5 years, insiders at OPKO Health, Inc. have bought $9.56M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: FROST PHILLIP MD ET AL (CEO & Chairman) — $87.01M. Zerhouni Elias A. (Vice Chairman and President) — $1.03M. HSIAO JANE PH D (Vice Chairman & CTO) — $546,797.
The last purchase of 125,000 shares for transaction amount of $199,375 was made by FROST PHILLIP MD ET AL (CEO & Chairman) on 2024‑12‑13.
2024-12-13 | CEO & Chairman | 125,000 0.0182% | $1.59 | $199,375 | +0.63% | |||
2024-12-11 | CEO & Chairman | 500,000 0.0713% | $1.56 | $781,050 | +0.63% | |||
2024-11-29 | CEO & Chairman | 199,072 0.0291% | $1.53 | $305,376 | +2.60% | |||
2024-11-22 | CEO & Chairman | 100,000 0.0147% | $1.59 | $159,000 | 0.00% | |||
2024-11-14 | CEO & Chairman | 100,000 0.0146% | $1.62 | $161,980 | +1.25% | |||
2024-11-08 | CEO & Chairman | 280,183 0.0399% | $1.50 | $421,535 | +3.95% | |||
2024-05-23 | CEO & Chairman | 100,000 0.0142% | $1.27 | $126,937 | +17.19% | |||
2024-05-17 | CEO & Chairman | 163,997 0.0229% | $1.29 | $211,195 | +14.50% | |||
2024-03-18 | CEO & Chairman | 500,000 0.0725% | $0.87 | $437,100 | +66.96% | |||
2024-03-14 | CEO & Chairman | 500,000 0.0693% | $0.89 | $444,300 | +62.07% | |||
2024-03-13 | CEO & Chairman | 500,000 0.0723% | $0.93 | $463,750 | +53.61% | |||
2024-03-12 | CEO & Chairman | 600,000 0.0865% | $0.93 | $559,380 | +54.11% | |||
2024-02-28 | CEO & Chairman | 500,000 0.0718% | $0.99 | $496,150 | +43.07% | |||
2024-02-21 | CEO & Chairman | 1M 0.1283% | $0.99 | $991,700 | +38.61% | |||
2024-02-07 | CEO & Chairman | 1.5M 0.1855% | $0.98 | $1.46M | +37.00% | |||
2024-01-29 | director | 30,000 0.0038% | $0.99 | $29,838 | +31.40% | |||
2024-01-19 | CEO & Chairman | 500,000 0.0634% | $0.98 | $488,650 | +35.81% | |||
2024-01-18 | CEO & Chairman | 400,000 0.0506% | $0.97 | $386,200 | +37.56% | |||
2024-01-17 | Vice Chairman & CTO | 150,000 0.0187% | $0.95 | $142,500 | +37.70% | |||
2024-01-16 | CEO & Chairman | 1M 0.1308% | $0.95 | $954,300 | +43.19% |
FROST PHILLIP MD ET AL | CEO & Chairman | 212536477 31.1417% | $1.54 | 1149 | 0 | +10.39% |
HSIAO JANE PH D | Vice Chairman & CTO | 27999880 4.1026% | $1.54 | 27 | 0 | +7.49% |
Zerhouni Elias A. | Vice Chairman and President | 20327814 2.9785% | $1.54 | 2 | 0 | <0.0001% |
Rubin Steven D | Executive VP-Administration | 6187732 0.9066% | $1.54 | 15 | 2 | <0.0001% |
PAGANELLI JOHN A | director | 384340 0.0563% | $1.54 | 6 | 0 | <0.0001% |
BlackRock | $39.87M | 4.77 | 33.23M | -10.11% | -$4.48M | <0.01 | |
The Vanguard Group | $35.4M | 4.23 | 29.5M | -25.79% | -$12.3M | <0.01 | |
State Street | $12.24M | 1.46 | 10.2M | +9.63% | +$1.08M | <0.01 | |
Geode Capital Management | $11.97M | 1.43 | 9.97M | +2.6% | +$302,659.93 | <0.01 | |
Charles Schwab | $6.97M | 0.83 | 5.81M | +1.32% | +$90,717.60 | <0.01 |